| Jinel Chetan Patel, NP-C | |
|
4 Paragon Way, Freehold, NJ 07728-7804 | |
| (732) 462-9800 | |
| Not Available |
| Full Name | Jinel Chetan Patel |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 4 Paragon Way, Freehold, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164003273 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2200X | Nurse Practitioner - Adult Health | 26NJ01138700 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Schweiger Dermatology Pc | 0143442806 | 131 |
News Archive
Tranzyme Pharma, a clinical-stage biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, announced today that they have entered into a licensing agreement that provides Norgine with the exclusive rights to develop and commercialize Tranzyme's novel ghrelin agonist, ulimorelin (TZP-101), in Europe, Australia, New Zealand, the Middle East, South Africa and North Africa. Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings.
Synovis Life Technologies, Inc., has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler®, an innovative extension of the company's well-established Microvascular Anastomotic Coupler used in several surgical procedures to connect small blood vessels more quickly and with equal or greater reliability than hand suturing. The Flow Coupler incorporates Doppler technology to immediately measure blood flow after connecting the small blood vessels.
The Wall Street Journal: "Rite Aid Corp. agreed to pay $1 million to settle potential violations of government privacy rules after regulators said it failed to protect customers' and employees' financial and medical information. The drug-store chain's agreement with the Federal Trade Commission requires the company to establish an information-security program and obtain a third-party audit of its compliance to that effect every two years for the next 20 years."
CPEX Pharmaceuticals, Inc. today announced that it has filed definitive proxy materials with the Securities and Exchange Commission (SEC) for its 2010 Annual Meeting of Stockholders. The Company has nominated Robert Forrester, a highly qualified independent director candidate, for election to the Board of Directors at the meeting.
› Verified 3 days ago
| Entity Name | Schweiger Dermatology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104229392 PECOS PAC ID: 0143442806 Enrollment ID: O20141112002172 |
News Archive
Tranzyme Pharma, a clinical-stage biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, announced today that they have entered into a licensing agreement that provides Norgine with the exclusive rights to develop and commercialize Tranzyme's novel ghrelin agonist, ulimorelin (TZP-101), in Europe, Australia, New Zealand, the Middle East, South Africa and North Africa. Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings.
Synovis Life Technologies, Inc., has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler®, an innovative extension of the company's well-established Microvascular Anastomotic Coupler used in several surgical procedures to connect small blood vessels more quickly and with equal or greater reliability than hand suturing. The Flow Coupler incorporates Doppler technology to immediately measure blood flow after connecting the small blood vessels.
The Wall Street Journal: "Rite Aid Corp. agreed to pay $1 million to settle potential violations of government privacy rules after regulators said it failed to protect customers' and employees' financial and medical information. The drug-store chain's agreement with the Federal Trade Commission requires the company to establish an information-security program and obtain a third-party audit of its compliance to that effect every two years for the next 20 years."
CPEX Pharmaceuticals, Inc. today announced that it has filed definitive proxy materials with the Securities and Exchange Commission (SEC) for its 2010 Annual Meeting of Stockholders. The Company has nominated Robert Forrester, a highly qualified independent director candidate, for election to the Board of Directors at the meeting.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jinel Chetan Patel, NP-C 4 Paragon Way, Freehold, NJ 07728-7804 Ph: (732) 462-9800 | Jinel Chetan Patel, NP-C 4 Paragon Way, Freehold, NJ 07728-7804 Ph: (732) 462-9800 |
News Archive
Tranzyme Pharma, a clinical-stage biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, announced today that they have entered into a licensing agreement that provides Norgine with the exclusive rights to develop and commercialize Tranzyme's novel ghrelin agonist, ulimorelin (TZP-101), in Europe, Australia, New Zealand, the Middle East, South Africa and North Africa. Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings.
Synovis Life Technologies, Inc., has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler®, an innovative extension of the company's well-established Microvascular Anastomotic Coupler used in several surgical procedures to connect small blood vessels more quickly and with equal or greater reliability than hand suturing. The Flow Coupler incorporates Doppler technology to immediately measure blood flow after connecting the small blood vessels.
The Wall Street Journal: "Rite Aid Corp. agreed to pay $1 million to settle potential violations of government privacy rules after regulators said it failed to protect customers' and employees' financial and medical information. The drug-store chain's agreement with the Federal Trade Commission requires the company to establish an information-security program and obtain a third-party audit of its compliance to that effect every two years for the next 20 years."
CPEX Pharmaceuticals, Inc. today announced that it has filed definitive proxy materials with the Securities and Exchange Commission (SEC) for its 2010 Annual Meeting of Stockholders. The Company has nominated Robert Forrester, a highly qualified independent director candidate, for election to the Board of Directors at the meeting.
› Verified 3 days ago
Deborah A Foley, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 901 W Main St, Freehold, NJ 07728 Phone: 732-431-2000 | |
Lori Shakour, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4 Paragon Way Ste 300, Freehold, NJ 07728 Phone: 732-462-9800 | |
Jennifer Levitt, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 35 Court St Ste 1c, Freehold, NJ 07728 Phone: 609-582-4700 Fax: 279-300-3710 | |
Diane Yacono, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 901 W Main St, Freehold, NJ 07728 Phone: 732-294-2674 Fax: 732-761-8084 | |
Ms. Christine Coyle, AGACNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3499 Route 9 N, Freehold, NJ 07728 Phone: 732-370-3563 | |
Ms. Kristen Renee Beer, AGPCNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 326 Professional View Dr, Freehold, NJ 07728 Phone: 732-431-8400 | |
Rosemarie Encinas Gozum, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 77 Schanck Rd, Freehold, NJ 07728 Phone: 732-725-1415 |